The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Liver Biopsy-Global Market Insights and Sales Trends 2024
Synopsis
Liver biopsy is the biopsy (removal of a small sample of tissue) from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment.
The global Liver Biopsy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Liver Biopsy in various end use industries. The expanding demands from the Hospitals & Clinics, Diagnostic Centers and Others,, are propelling Liver Biopsy market. Percutaneous, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transjugular segment is estimated at % CAGR for the next seven-year period.
Liver biopsies may be taken percutaneously (via a needle through the skin), transvenously (through the blood vessels), endoscopically (through endoscopic ultrasound fine needle biopsy), or directly during abdominal surgery. The sample is examined by microscope, and may be processed further by immunohistochemistry, determination of iron and copper content, and microbiological culture if tuberculosis is suspected.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Liver Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Liver Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Liver Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Liver Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Liver Biopsy covered in this report include Cook Medical, Boston Scientific, Hologic, MDxHealth, CR Bard, Intact Medical, Veran Medical and Leica Biosystems, etc.
The global Liver Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cook Medical
Boston Scientific
Hologic
MDxHealth
CR Bard
Intact Medical
Veran Medical
Leica Biosystems
Global Liver Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liver Biopsy market, Segment by Type:
Percutaneous
Transjugular
Laparoscopic
Global Liver Biopsy market, by Application
Hospitals & Clinics
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Liver Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Liver biopsy is the biopsy (removal of a small sample of tissue) from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment.
The global Liver Biopsy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Liver Biopsy in various end use industries. The expanding demands from the Hospitals & Clinics, Diagnostic Centers and Others,, are propelling Liver Biopsy market. Percutaneous, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transjugular segment is estimated at % CAGR for the next seven-year period.
Liver biopsies may be taken percutaneously (via a needle through the skin), transvenously (through the blood vessels), endoscopically (through endoscopic ultrasound fine needle biopsy), or directly during abdominal surgery. The sample is examined by microscope, and may be processed further by immunohistochemistry, determination of iron and copper content, and microbiological culture if tuberculosis is suspected.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Liver Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Liver Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Liver Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Liver Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Liver Biopsy covered in this report include Cook Medical, Boston Scientific, Hologic, MDxHealth, CR Bard, Intact Medical, Veran Medical and Leica Biosystems, etc.
The global Liver Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cook Medical
Boston Scientific
Hologic
MDxHealth
CR Bard
Intact Medical
Veran Medical
Leica Biosystems
Global Liver Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liver Biopsy market, Segment by Type:
Percutaneous
Transjugular
Laparoscopic
Global Liver Biopsy market, by Application
Hospitals & Clinics
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Liver Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Liver Biopsy
1.1 Liver Biopsy Market Overview
1.1.1 Liver Biopsy Product Scope
1.1.2 Liver Biopsy Market Status and Outlook
1.2 Global Liver Biopsy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Liver Biopsy Market Size by Region (2018-2029)
1.4 Global Liver Biopsy Historic Market Size by Region (2018-2023)
1.5 Global Liver Biopsy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Liver Biopsy Market Size (2018-2029)
1.6.1 North America Liver Biopsy Market Size (2018-2029)
1.6.2 Europe Liver Biopsy Market Size (2018-2029)
1.6.3 Asia-Pacific Liver Biopsy Market Size (2018-2029)
1.6.4 Latin America Liver Biopsy Market Size (2018-2029)
1.6.5 Middle East & Africa Liver Biopsy Market Size (2018-2029)
2 Liver Biopsy Market by Type
2.1 Introduction
2.1.1 Percutaneous
2.1.2 Transjugular
2.1.3 Laparoscopic
2.2 Global Liver Biopsy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Liver Biopsy Historic Market Size by Type (2018-2023)
2.2.2 Global Liver Biopsy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Liver Biopsy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Liver Biopsy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Liver Biopsy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Liver Biopsy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Liver Biopsy Revenue Breakdown by Type (2018-2029)
3 Liver Biopsy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals & Clinics
3.1.2 Diagnostic Centers
3.1.3 Others
3.2 Global Liver Biopsy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Liver Biopsy Historic Market Size by Application (2018-2023)
3.2.2 Global Liver Biopsy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Liver Biopsy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Liver Biopsy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Liver Biopsy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Liver Biopsy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Liver Biopsy Revenue Breakdown by Application (2018-2029)
4 Liver Biopsy Competition Analysis by Players
4.1 Global Liver Biopsy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liver Biopsy as of 2022)
4.3 Date of Key Players Enter into Liver Biopsy Market
4.4 Global Top Players Liver Biopsy Headquarters and Area Served
4.5 Key Players Liver Biopsy Product Solution and Service
4.6 Competitive Status
4.6.1 Liver Biopsy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cook Medical
5.1.1 Cook Medical Profile
5.1.2 Cook Medical Main Business
5.1.3 Cook Medical Liver Biopsy Products, Services and Solutions
5.1.4 Cook Medical Liver Biopsy Revenue (US$ Million) & (2018-2023)
5.1.5 Cook Medical Recent Developments
5.2 Boston Scientific
5.2.1 Boston Scientific Profile
5.2.2 Boston Scientific Main Business
5.2.3 Boston Scientific Liver Biopsy Products, Services and Solutions
5.2.4 Boston Scientific Liver Biopsy Revenue (US$ Million) & (2018-2023)
5.2.5 Boston Scientific Recent Developments
5.3 Hologic
5.3.1 Hologic Profile
5.3.2 Hologic Main Business
5.3.3 Hologic Liver Biopsy Products, Services and Solutions
5.3.4 Hologic Liver Biopsy Revenue (US$ Million) & (2018-2023)
5.3.5 MDxHealth Recent Developments
5.4 MDxHealth
5.4.1 MDxHealth Profile
5.4.2 MDxHealth Main Business
5.4.3 MDxHealth Liver Biopsy Products, Services and Solutions
5.4.4 MDxHealth Liver Biopsy Revenue (US$ Million) & (2018-2023)
5.4.5 MDxHealth Recent Developments
5.5 CR Bard
5.5.1 CR Bard Profile
5.5.2 CR Bard Main Business
5.5.3 CR Bard Liver Biopsy Products, Services and Solutions
5.5.4 CR Bard Liver Biopsy Revenue (US$ Million) & (2018-2023)
5.5.5 CR Bard Recent Developments
5.6 Intact Medical
5.6.1 Intact Medical Profile
5.6.2 Intact Medical Main Business
5.6.3 Intact Medical Liver Biopsy Products, Services and Solutions
5.6.4 Intact Medical Liver Biopsy Revenue (US$ Million) & (2018-2023)
5.6.5 Intact Medical Recent Developments
5.7 Veran Medical
5.7.1 Veran Medical Profile
5.7.2 Veran Medical Main Business
5.7.3 Veran Medical Liver Biopsy Products, Services and Solutions
5.7.4 Veran Medical Liver Biopsy Revenue (US$ Million) & (2018-2023)
5.7.5 Veran Medical Recent Developments
5.8 Leica Biosystems
5.8.1 Leica Biosystems Profile
5.8.2 Leica Biosystems Main Business
5.8.3 Leica Biosystems Liver Biopsy Products, Services and Solutions
5.8.4 Leica Biosystems Liver Biopsy Revenue (US$ Million) & (2018-2023)
5.8.5 Leica Biosystems Recent Developments
6 North America
6.1 North America Liver Biopsy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Liver Biopsy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Liver Biopsy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Liver Biopsy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Liver Biopsy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Liver Biopsy Market Dynamics
11.1 Liver Biopsy Industry Trends
11.2 Liver Biopsy Market Drivers
11.3 Liver Biopsy Market Challenges
11.4 Liver Biopsy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
